Detalhe da pesquisa
1.
Predictive value of an exosomal microRNA-based signature for tumor immunity in cervical cancer patients treated with chemoradiotherapy.
Med Mol Morphol
; 56(1): 38-45, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36367588
2.
Immunohistological evaluation of patients treated with intra-arterial chemoradiotherapy and surgery for oral cancer.
Med Mol Morphol
; 56(4): 288-296, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37507576
3.
Combined chemoradiotherapy and programmed cell death-ligand 1 blockade leads to changes in the circulating T-cell receptor repertoire of patients with non-small-cell lung cancer.
Cancer Sci
; 113(12): 4394-4400, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36069051
4.
Prediction of treatment response from the microenvironment of tumor immunity in cervical cancer patients treated with chemoradiotherapy.
Med Mol Morphol
; 54(3): 245-252, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-33963949
5.
Prediction of late adverse events in pelvic cancer patients receiving definitive radiotherapy using radiation-induced gamma-H2AX foci assay.
J Radiat Res
; 64(6): 948-953, 2023 Nov 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37839163
6.
Radiotherapy for HPV-related cancers: prediction of therapeutic effects based on the mechanism of tumor immunity and the application of immunoradiotherapy.
Jpn J Radiol
; 40(5): 458-465, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-34973113